ClearPoint Neuro (CLPT) Cost of Revenue (2011 - 2026)

ClearPoint Neuro has disclosed Cost of Revenue across 15 years of filings, most recently posting $4.2 million for Q2 2026.

• In Q2 2026, Cost of Revenue rose 13.97% year-over-year to $4.2 million; the TTM figure through Jun 2026 stood at $15.8 million (up 18.9% YoY), while the FY2025 annual figure was $14.3 million, up 16.39% from the prior year.
• Cost of Revenue came in at $4.2 million for Q2 2026 at ClearPoint Neuro, down from $4.4 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $4.4 million in Q1 2026 to a low of $1.5 million in Q3 2022.
• Average Cost of Revenue over 5 years is $2.9 million, with a median of $2.9 million recorded in 2024.
• The largest YoY upside for Cost of Revenue was 70.76% in 2022 against a maximum downside of 4.31% in 2022.
• Over 5 years, Cost of Revenue stood at $1.8 million in 2022, then surged by 54.7% to $2.8 million in 2023, then gained by 7.58% to $3.0 million in 2024, then soared by 33.13% to $4.0 million in 2025, then gained by 4.09% to $4.2 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $4.2 million in Q2 2026, $4.4 million in Q1 2026, and $4.0 million in Q4 2025.